JRC Response to Emergencies and Disasters
|
JRC Response to Emergencies and Disasters |
|
| Click above to go to Disasters Home page | ||
Avian Flu Disease Monitoring, 2006 |
login |
|
Note: If you want to zoom into the image, click the image and presss Z, to reduce the zoom factor press A
|
|
||||||||||||||||||||||||||||
|
Avian influenza - situation in Thailand
Avian influenza - situation in Thailand 26 July 2006 The Ministry of Public Health in Thailand has confirmed a case of human infection with H5N1 avian influenza. The patient, a 17-year-old man from Thap Khlo district of Phichit province in the north, developed symptoms on 15 July, was hospitalized on 20 July and died on 24 July. On 10 July, the young man had buried the carcasses of dead chickens. This case coincides with a recurrence of a confirmed H5N1 outbreak in animals in the province. Control measures have been implemented to contain the animal outbreak and human surveillance has been strengthened. Field investigations have not found any indications of respiratory illness in close contacts of the young man. This is the first human case of H5N1 infection reported from Thailand in 2006. |
| Get more items... |
News from EMM|
New plan to curb bird flu in Egypt (Middle East Online)
Sale of poultry between any of Egyptâ??s 29 governorates is to be banned in bid to fight spread of avian influenza. |
|
Bird flu hits northern province of Vietnam (People's Daily)
Bird flu is occurring in the northern province Bac Ninh of Vietnam, raising the total number of affected provinces in the country to six, according to the Department of Animal Health of Vietnam's Ministry of Agriculture and Rural Development on Monday. The bird flu struck a local farm of Bac Ninh province, causing 200 fowls out of 400 die, said the department. Samples of death fowls were tested ... |
|
Cephalon Australia granted exclusive license to develop Innate Immune's antibodies for treatment of asthma, SLE (News-Medical-Net)
Innate Immune, Inc., a privately held biotechnology company, today announced that it has granted to Cephalon Australia Pty Ltd an exclusive license to patents for the development of its antibodies for the treatment of asthma and systemic lupus erythematosis (SLE). |
| Get more items... |
If you have any question on the web site please
contact A. Annuziato
45832
Get the 
